Pediatric Schizophrenia or Bipolar 1 Disorder - Wake Research

Pediatric Schizophrenia or Bipolar 1 Disorder

A Study For Children With Schizophrenia Or Bipolar I Disorder

To qualify, you must:

  • Ages 10-17
  • Be diagnosed with Schizophrenia or Bipolar 1 Disorder
  • Be an outpatient or be able to be treated on an outpatient basis
  • Currently treated with olanzapine or has had an inadequate response to current antipsychotic

Qualified participants will receive:

  • Study-related medication at no cost
  • Study-related medical exams at no cost
  • Compensation for time

Why Participate?

Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.


The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.


Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.

Pharmacology Research Institute - Encino

Main Office

Our Hours
Mon: 8AM – 5PM
Tues: 8AM – 5PM
Wed: 8AM – 7PM
Thurs: 8AM – 7PM
Fri: 8AM – noon

5400 Balboa Blvd.
Suite 120
Encino, CA 91316